ライフサイエンスコーパス: atrial flutter

1 ure (the latter was performed for persistent atrial flutter).

2 theter ablation similar to isthmus block for atrial flutter.

3 e to first-line therapy for the treatment of atrial flutter.

4 e incidence and mechanisms of atypical right atrial flutter.

5 at 45 sites in 10 consecutive patients with atrial flutter.

6 he standard initial therapeutic approach for atrial flutter.

7 d to subsequently initiate isthmus-dependent atrial flutter.

8 e to subsequently initiate isthmus-dependent atrial flutter.

9 ht to characterize the posterior boundary of atrial flutter.

10 atrium during counterclockwise and clockwise atrial flutter.

11 prophylaxis against atrial fibrillation and atrial flutter.

12 and contact electrograms was 0.85+/-0.17 in atrial flutter.

13 tinguished isthmus from nonisthmus dependent atrial flutter.

14 pacemaker and only 10 (4.1%) had documented atrial flutter.

15 trigger rather than a consequence of type I atrial flutter.

16 of slow conduction in the reentry circuit of atrial flutter.

17 re thought to be rare after cardioversion of atrial flutter.

18 relation with the duration of previous AF or atrial flutter.

19 lism in patients undergoing cardioversion of atrial flutter.

20 B) to the isthmus in 14 patients with type I atrial flutter.

21 atrial fibrillation and 14 (74%) of 19 with atrial flutter.

22 65 +/- 52 s-1, respectively (p < 0.001), in atrial flutter.

23 right atrium) to assess efficacy at inducing atrial flutter.

24 ecific (99%) for impending organization into atrial flutter.

25 advance in the pharmacologic termination of atrial flutter.

26 he excitable gap of the reentrant circuit in atrial flutter.

27 ents scheduled for elective cardioversion of atrial flutter.

28 seven were attributable to causes other than atrial flutter.

29 ted by patients with atrial fibrillation and atrial flutter.

30 for the treatment of atrial fibrillation and atrial flutter.

31 sistent AF, 6% had paroxysmal AF, and 5% had atrial flutter.

32 nt circuits in the majority of patients with atrial flutter.

33 y right or left ventricular pacing, and (iv) atrial flutter.

34 brillation developed in 56% of patients with atrial flutter.

35 l ectopic tachycardia, and 3 of 9 (33%) with atrial flutter.

36 atrial myopathy seems to promote left septal atrial flutter.

37 of the TI isthmus-dependent clockwise right atrial flutters.

38 disposing risks were labeled as having "lone atrial flutter."

39 hear rates were also higher in patients with atrial flutter (103 +/- 82 vs. 59 +/- 37 s-1, p < 0.001)

40 Among those with atrial flutter 16% were attributable to heart failure an

41 recurrences in patients with any history of atrial flutter (16.7% vs. 60.9%, p = 0.009).

42 ersion was less pronounced in the group with atrial flutter (27 +/- 18 cm/s for atrial flutter vs. 15

43 patients with chronic AF and 13 with chronic atrial flutter (3 weeks to 3 years in duration) the rela

44 ial free wall activation direction as during atrial flutter; (4) another delay on the lateral right a

45 14 cm/s after cardioversion, p < 0.001) and atrial flutter (42 +/- 19 to 27 +/- 18 cm/s, respectivel

46 thmic drugs, 38% had AF, 17% had both AF and atrial flutter, 9% had persistent atrial flutter, and 3%

47 ation, invasive electrophysiology testing or atrial flutter ablation.

48 or programmed electrical stimulation-induced atrial flutter acceleration in human subjects.

49 In five patients, 27 episodes of atrial flutter acceleration were induced by single extra

50 ical prediction rule for atrial fibrillation/atrial flutter (AF) after coronary artery bypass graftin

51 ved for treatment of atrial fibrillation and atrial flutter (AF).

52 nction before and after catheter ablation of atrial flutter (AFI).

53 We studied the safety and efficacy of atrial flutter (AFL) ablation using 8- or 10-mm electrod

54 of this study was to assess the incidence of atrial flutter (AFL) after pulmonary vein antrum isolati

55 Atrial flutter (AFL) and atrial fibrillation (AF) freque

56 participant in atrial arrhythmias, including atrial flutter (AFL) and atrial fibrillation (AF).

57 ngs action potential duration and terminates atrial flutter (AFL) and fibrillation (AF), but the mech

58 In patients with atrial flutter (AFL) and postoperative right atrial inci

59 nce of new-onset atrial fibrillation (AF) or atrial flutter (AFL) and their influence on clinical out

60 terclockwise isthmus-dependent (CCWID) right atrial flutter (AFL) and to attempt to correlate F-wave

61 erms counterclockwise (CC) and clockwise (C) atrial flutter (Afl) are used to describe right atrial a

62 ization to lisinopril reduces incident AF or atrial flutter (AFL) compared with chlorthalidone in a l

63 g interval (PPI) upon entrainment of typical atrial flutter (AFL) from the cavotricuspid isthmus (CTI

64 of 28 (8%) of 372 consecutive patients with atrial flutter (AFL) had 36 episodes of sustained atypic

65 ought to characterize the clinical nature of atrial flutter (AFL) in a large cohort of infants.

66 his study sought to 1) establish whether the atrial flutter (AFL) inducible acutely occurs spontaneou

67 n for those with atrial fibrillation (AF) or atrial flutter (AFL) receiving long-term treatmentwith c

68 The mechanisms of an atrial flutter (AFL) that is more rapid and at times mor

69 the prevalence and clinical significance of atrial flutter (AFL) that occurs during catheter ablatio

70 hanisms underlying the transition of typical atrial flutter (Afl) to fibrillation (AF) remain unclear

71 de in converting atrial fibrillation (AF) or atrial flutter (AFl) to sinus rhythm (SR) and maintainin

72 The purpose of this study was to separate atrial flutter (AFL) with atypical F waves from fibrilla

73 A, 59% had atrial fibrillation (AF), 14% had atrial flutter (AFL), and 27% had both AF and AFL.

74 Four patients had right atrium incisional atrial flutter (AFL), and 6 had LA incisional AFL, which

75 ir pattern during counterclockwise (CCW) CTI atrial flutter (AFL), except for decreased amplitude of

76 ndergoing radiofrequency ablation of typical atrial flutter (AFL).

77 nce and quality of life in coexistent AF and atrial flutter (AFL).

78 , often coexists with the related arrhythmia atrial flutter (AFL).

79 ncy ablation of atrial fibrillation (AF) and atrial flutter (AFL).

80 ionship between atrial fibrillation (AF) and atrial flutter (AFL).

81 In patients presenting with atrial flutter after LA ablation, entrainment mapping sh

82 The high recurrence rate of atrial flutter after presumed successful ablation may be

83 t catheter ablation for recurrent AF or left atrial flutter after the hybrid procedure.

84 endage stunning also occurs in patients with atrial flutter, although to a lesser degree than in thos

85 of counterclockwise and/or clockwise typical atrial flutter, an additional atypical atrial flutter wa

86 of ibutilide converted 54% of patients with atrial flutter and 39% of patients with atrial fibrillat

87 Patients were analyzed for recurrence of atrial flutter and atrial fibrillation between 3 months

88 case of a 62-year old female with paroxysmal atrial flutter and atrial fibrillation, whose cardiac co

89 15 patients with AF and 5 patients each with atrial flutter and atrioventricular nodal reentrant tach

90 gnificantly different from that required for atrial flutter and AVNRT.

91 s contrast are not uncommon in patients with atrial flutter and cardioversion may be associated with

92 Sixteen patients had inducible AF or atrial flutter and could be tested after dual-site atria

93 ation between suppression of inducible AF or atrial flutter and demographic or clinical patient chara

94 LLR is a subtype of right atrial flutter and depends on conduction through the TA-

95 100302, and the partial agonist cisapride on atrial flutter and fibrillation induced in swine were st

96 n placebo in the pharmacologic conversion of atrial flutter and fibrillation to sinus rhythm.

97 idence of atrial arrhythmias, with inducible atrial flutter and fibrillation.

98 Previous studies using ICE during mapping of atrial flutter and inappropriate sinus tachycardia have

99 date discusses the classification schemes of atrial flutter and macroreentrant atrial tachycardias, r

100 ces between patients with cardioversion from atrial flutter and those with cardioversion from AF.

101 l appendage stunning occurs in patients with atrial flutter and to compare left atrial appendage func

102 mboembolic events in the presence of chronic atrial flutter and to determine the impact of anticoagul

103 nd highlights recent ablation approaches for atrial flutters and macroreentrant atrial tachycardias.

104 oth AF and atrial flutter, 9% had persistent atrial flutter, and 3% had paroxysmal AF on antiarrhythm

105 in patients who have atrial fibrillation or atrial flutter, and data point to an important role for

106 ing sinus rhythm, demonstrate reentry during atrial flutter, and describe right atrial activation dur

107 ed with greater experience using Sotalol for atrial flutter, and digoxin and amiodarone for 1: 1 reci

108 from 17 simulations of atrial fibrillation, atrial flutter, and focal atrial tachycardia.

109 quency (RF) ablation of atrial fibrillation, atrial flutter, and nonidiopathic ventricular tachycardi

110 The rate of readmission for recurrent AF, atrial flutter, and/or repeat ablation was 21.7% by 1 ye

111 Patients with chronic atrial flutter are at an increased risk of thromboemboli

112 These data suggest that patients with atrial flutter are at risk for thromboembolic events aft

113 At highest risk of developing atrial flutter are men, the elderly and individuals with

114 de catheters was characteristic of clockwise atrial flutter around the TA.

115 similar to that of counterclockwise typical atrial flutter around the tricuspid annulus (TA).

116 gency department with atrial fibrillation or atrial flutter as a primary or secondary diagnosis.

117 fractions (p = 0.0001), and more concomitant atrial flutter at baseline (p < 0.0001).

118 consecutive patients with ablation of type I atrial flutter, atrial fibrillation was documented in 28

119 We identified D1275N in a patient with atrial flutter, atrial standstill, conduction disease, a

120 nced the first recurrence of symptomatic AF, atrial flutter, atrial tachycardia (HR, 0.56 [95% CI, 0.

121 bsequent AT (comprising atrial fibrillation, atrial flutter, atrial tachycardia, and supraventricular

122 l AV-conduction block (2 cases), (post)ictal atrial flutter/atrial fibrillation (14 cases) and postic

123 ordant alternans, underlies the induction of atrial flutter/atrial fibrillation by atrial ectopic foc

124 each foci location, a vulnerable window for atrial flutter/atrial fibrillation induction was identif

125 The mechanisms underlying paroxysmal atrial flutter/atrial fibrillation initiation by ectopic

126 at procedures and long-term recurrence of AF/atrial flutter/atrial tachycardia are significantly lowe

127 s, 12-month freedom from atrial fibrillation/atrial flutter/atrial tachycardia recurrence was 72.5%.

128 At 1-year follow-up, freedom from AF/atrial flutter/atrial tachycardia recurrence was signifi

129 es (47 patients with AF and 16 patients with atrial flutter/atrial tachycardia) after the initial pro

130 ing order of frequency, atrial fibrillation, atrial flutter, atrioventricular nodal reentry, Wolff-Pa

131 investigated the mechanism of initiation of atrial flutter, before ablation, to determine the site o

132 ime of conversion and included appearance of atrial flutter, bradycardia, pauses and junctional rhyth

133 rrhythmia is frequently referred to as "left atrial flutter," but the mechanism and best ablation str

134 longs atrial cycle length, but conversion of atrial flutter by ibutilide is characterized by increase

135 Atrial flutter can arise in the right atrial free wall.

136 Although atrial flutter can now be cured, there are no reports on

137 Catheter cryoablation of common atrial flutter causes much less patient discomfort than

138 nd demonstrating conduction block within the atrial flutter circuit after ablation.

139 stics of a novel macroreentrant form of left atrial flutter circuit.

140 s also had a lower adjusted risk of incident atrial flutter compared with whites, the risk of flutter

141 terms adverse effects, atrial fibrillation, atrial flutter, congestive heart failure, electrical sto

142 < 0.05) increased significantly just before atrial flutter conversion and remained unchanged in ibut

143 This form of atypical atrial flutter could account for spontaneous or inducibl

144 duced after lesion set completion, sustained atrial flutter could be induced in 25% of the hearts.

145 right atrium (283+/-52 ms); and (5) typical atrial flutter (cycle length, 245+/-38 ms).

146 hypothesis that the direction of rotation of atrial flutter depends on the pacing site from which it

147 During follow-up, left atrial flutter developed in 19% of patients and was stil

148 dents was used to ascertain all new cases of atrial flutter diagnosed from July 1, 1991 to June 30, 1

149 Post-ablation atrial flutter did not differ between groups: 5.1% in PV

150 "Atrial fibrillation" was defined as AF or atrial flutter documented by electrocardiogram or prior

151 illation (166+/-236 seconds) converting into atrial flutter during electrophysiological evaluation we

152 rience cavotricuspid isthmus (CTI)-dependent atrial flutter during follow-up.

153 (3) In 10 cases of atrial tachycardia/atrial flutter, ECM accurately identified the chamber of

154 ry sinus ostium can suppress inducible AF or atrial flutter elicited after single-site high right atr

155 rhythm, A-V dissociation, sinus bradycardia, atrial flutter, escape-capture bigeminy, and atrial prem

156 Patients with atrial flutter exhibited greater left atrial appendage f

157 c failure, shock, atrioventricular block and atrial flutter/ fibrillation were more common among diab

158 Onset of atrial flutter/fibrillation (AFF) in patients who have u

159 c target in the control of AVN conduction in atrial flutter/fibrillation, one of the most common arrh

160 s tricuspid regurgitation was for those with atrial flutter/fibrillation.

161 erclockwise (CCW) and clockwise (CW) typical atrial flutter (Fl) in patients with and without structu

162 Atrial flutter frequently occurs in patients with AF.

163 logy laboratory for cardioversion of chronic atrial flutter from 1986 to 1996.

164 350 ms, APD90 was shorter in both the AF and atrial flutter groups than in the control group (p < 0.0

165 Patients with atrial flutter had a greater response to dofetilide (54%

166 er adjustment for age and sex, patients with atrial flutter had a higher incidence of thromboembolic

167 Lone atrial flutter has a stroke risk at least as high as lon

168 Atrial flutter has been mapped using sequential techniqu

169 The electrophysiologic substrate of typical atrial flutter has not been well characterized.

170 Atrial flutter has not recurred in any patient (follow-u

171 Previous studies of atrial flutter have found linear block at the crista ter

172 In the patients with atrial flutter, ibutilide had a significantly higher suc

173 ition to terminating atrial fibrillation and atrial flutter, ibutilide significantly reduces human at

174 ant tachycardia (IART) and isthmus-dependent atrial flutter (IDAF) in patients presenting with suprav

175 this study was to separate isthmus-dependent atrial flutter (IDAFL) from non-isthmus-dependent atrial

176 of 100 randomized patients (for AF in 30 and atrial flutter in 4).

177 RS-100302 terminated atrial flutter in 6 of 8 animals and atrial fibrillation

178 ation in 26 percent of patients and atypical atrial flutter in 6 percent.

179 The only complication was left atrial flutter in a patient who underwent LACA.

180 nal rhythm precedes the spontaneous onset of atrial flutter in an animal model, but few data are avai

181 ed and prevented the reinduction of atypical atrial flutter in each patient.

182 characterizing the various forms of atypical atrial flutter in humans are limited.

183 l beat-to-beat variations in cycle length of atrial flutter in humans has not been fully explained.

184 whether chronic atrial fibrillation (AF) and atrial flutter in patients lead to electrical remodeling

185 Atrial flutter in the absence of other arrhythmias has a

186 More patients had atrial fibrillation or atrial flutter in the albiglutide group (35 [1.4%] of 25

187 to determine the incidence and predictors of atrial flutter in the general population.

188 ts with at least two episodes of symptomatic atrial flutter in the last four months were randomized t

189 population, we estimate 200,000 new cases of atrial flutter in this country annually.

190 vely in patients with atrial fibrillation or atrial flutter, in patients undergoing cardioversion of

191 The risk of developing atrial flutter increased 3.5 times (p < 0.001) in subjec

192 Data from experimental models of atrial flutter indicate that macro-reentrant circuits ma

193 acing to prevent atrial fibrillation (AF) or atrial flutter induced by single-site atrial pacing and

194 Fifty episodes of atrial flutter induced in 11 animals were evaluated.

195 d atrial stimulation was performed for AF or atrial flutter induction.

196 Successful ablation of atrial flutter involves (1) mapping the atrial flutter t

197 Atrial flutter is a macroreentrant tachyarrhythmia most

198 ng atrial fibrillation after presenting with atrial flutter is also reported.

199 Atrial flutter is characterized by a macroreentrant atri

200 Typical atrial flutter is defined on an electrocardiogram by the

201 re-entrant circuit to determine whether the atrial flutter is isthmus-dependent, non-isthmus-depende

202 The natural history of atrial flutter is not well defined.

203 anatomic and/or functional barriers, typical atrial flutter is sustained by a single reentrant circui

204 Atrial flutter is thought to be associated with a neglig

205 Although overdrive pacing for treating atrial flutter is well established, the efficacy of devi

206 ical studies with entrainment mapping of the atrial flutter isthmus for determining postpacing interv

207 te but have not systematically evaluated the atrial flutter isthmus in such patients.

208 We sought to determine the role of the atrial flutter isthmus in supporting IART in a group of

209 The fact that the atrial flutter isthmus is vulnerable to ablation suggest

210 ter repair of a congenital heart defect, the atrial flutter isthmus should be evaluated.

211 The atrial flutter isthmus was part of the circuit in 15 of

212 In most of our postoperative patients, the atrial flutter isthmus was part of the reentrant circuit

213 ) IARTs and in 14 of 15 (93.3%) cases at the atrial flutter isthmus.

214 ptomatic recurrence of AF/atrial tachycardia/atrial flutter lasting >30 seconds, determined 3 months

215 These data confirm that both AF and atrial flutter lead to electrical remodeling in the huma

216 AF and atrial flutter lead to marked, quantitatively similar de

217 dependent, or atypical; (2) interrupting the atrial flutter macroreentrant circuit with an ablation c

218 Atrial arrhythmias are frequent, and atrial flutter may be a marker for sudden death.

219 s intra-atrial block, sinus bradycardia, and atrial flutter, may be attributed to changes in atrial s

220 Seven patients had classic atrial flutter morphology on surface electrocardiogram (

221 /- 16 years) with symptomatic AF (n = 10) or atrial flutter (n = 10) were studied.

222 Sixty-three patients with atrial flutter (n = 19) or atrial fibrillation (n = 44)

223 (56%), who had either induced AF (n = 5) or atrial flutter (n = 4).

224 The cause was atrial fibrillation (n=13), atrial flutter (n=4), atrial tachycardia (n=3), idiopath

225 ias included cavotricuspid isthmus-dependent atrial flutter (n=7), non-isthmus-dependent right atrial

226 Atrial flutter never degenerated into fibrillation, even

227 l flutter (IDAFL) from non-isthmus-dependent atrial flutter (NIDAFL) from the electrocardiogram (ECG)

228 r could account for spontaneous or inducible atrial flutter observed in patients referred for ablatio

229 as seen in 7 patients, and isthmus-dependent atrial flutter occurred in 14 patients.

230 Left atrial flutter occurred in 17% and 27% of patients in ea

231 ce, atrial burst pacing consistently induced atrial flutter or AF in Casq2-/- mice and in isolated Ca

232 In patients with cardioversion from atrial flutter or AF, the steady state cycle length-APD9

233 boembolic events occurred during a rhythm of atrial flutter or after cardioversion to sinus rhythm.

234 rrence of atrial fibrillation, occurrence of atrial flutter or atrial tachycardia, use of antiarrhyth

235 ients with a history of atrial fibrillation, atrial flutter or both were randomly assigned to receive

236 ients with a history of atrial fibrillation, atrial flutter or both.

237 rences in patients with atrial fibrillation, atrial flutter or both.

238 ven patients (age range 22 to 92 years) with atrial flutter or fibrillation of 3 h to 90 days' (mean

239 17 anesthetized, open-chest, juvenile pigs, atrial flutter or fibrillation was induced by rapid righ

240 s rhythm and 15 patients after conversion of atrial flutter or fibrillation were evaluated.

241 ong atrial action potentials and may prevent atrial flutter or fibrillation without affecting ventric

242 Patients (n = 44) with bundle branch blocks, atrial flutter or fibrillation, pacemaker rhythm, recent

243 ied suddenly, and 29 had new-onset sustained atrial flutter or fibrillation.

244 es and may have relevance for maintenance of atrial flutter or fibrillation.

245 hythmias, and 865 (36%) having postoperative atrial flutter or fibrillation.

246 procainamide for conversion of recent-onset atrial flutter or fibrillation.

247 RM ablation terminated AF to sinus rhythm or atrial flutter or tachycardia in 59% (PAF), 37% (PeAF),

248 nth recurrence, defined as an episode of AF, atrial flutter, or atrial tachycardia lasting >30 second

249 elihood of freedom from atrial fibrillation, atrial flutter, or atrial tachycardia while not receivin

250 30 seconds (symptomatic or asymptomatic AF, atrial flutter, or atrial tachycardia), detected by eith

251 trial fibrillation versus 4 (21%) of 19 with atrial flutter (p < 0.05).

252 w-onset postoperative atrial fibrillation or atrial flutter (pAF) that could be related to rDA admini

253 rdings only for atrial fibrillation and some atrial flutter propagations patterns, and HDF filtering

254 ed the outcome at follow-up of patients with atrial flutter randomly assigned to drug therapy or RF a

255 istory of symptomatic atrial fibrillation or atrial flutter received placebo or azimilide (35 to 125

256 thmus (CTI) conduction block reduces typical atrial flutter recurrences after ablation.

257 establishment of a stable substrate for the atrial flutter reentrant circuit.

258 elocity, and medications in patients with AF/atrial flutter referred for DC cardioversion.

259 f therapy, end points included recurrence of atrial flutter, rehospitalization and quality of life.

260 In patients with inducible AF or atrial flutter, reinduction was then attempted during a

261 atrial fibrillation after ablation of type I atrial flutter remains an important clinical problem.

262 In a selected group of patients with atrial flutter, RF ablation could be considered a first-

263 Episodes of a right atrial flutter rhythm that was different from typical AF

264 esponse was observed in most cases of type I atrial flutter, signifying a fully excitable gap in all

265 the first population-based investigation of atrial flutter, suggests this curable condition is much

266 as exercise-induced atrial fibrillation (AF)/atrial flutter, supraventricular tachycardia (SVT), or A

267 onversion rates at all doses were higher for atrial flutter than for atrial fibrillation.

268 l fibrillation; in 3 episodes it was type II atrial flutter that appeared to generate atrial fibrilla

269 During mapping of VT and atrial flutter, the N + 1 difference correlated well wit

270 Except for atypical atrial flutter, there were no complications attributable

271 th cardioversion; postoperative AF excluding atrial flutter; time to first postoperative AF; number o

272 n of atrial flutter involves (1) mapping the atrial flutter to define the conduction zones within the

273 nts to convert either atrial fibrillation or atrial flutter to sinus rhythm.

274 e estimated lifetime risks for AF (including atrial flutter) to age 95 years, with death free of AF a

275 y Cause in Patients With Atrial Fibrillation/Atrial Flutter) trial, which demonstrated a significant

276 Thirty-five patients with type I atrial flutter underwent catheter mapping and ablation.

277 deviation, 68 years +/- 10) with symptomatic atrial flutter underwent isthmus ablation.

278 pothesis in patients undergoing ablation for atrial flutter using a novel ECG algorithm to detect sub

279 ocardial activation during the initiation of atrial flutter via fibrillation and the rarity of degene

280 roup with atrial flutter (27 +/- 18 cm/s for atrial flutter vs. 15 +/- 14 cm/s for atrial fibrillatio

281 Atrial flutter was 2.5 times more common in men (p < 0.0

282 Atrial flutter was induced in 52 (6.2%) of 838 attempted

283 pical atrial flutter, an additional atypical atrial flutter was mapped to the right atrial free wall.

284 Atrial flutter was present for at least 6 months.

285 However, atrial flutter was recorded after the completion of the

286 After era correction, the incidence of atrial flutter was similar and strongly associated with

287 In all 27 episodes, the onset of type I atrial flutter was through a transitional rhythm of vari

288 A total of 181 new cases of atrial flutter were diagnosed for an overall incidence o

289 18,201 patients with AF or atrial flutter were randomly assigned to receive apixaba

290 ogy on surface ECG consistent with clockwise atrial flutter were studied.

291 Twelve patients with typical atrial flutter were studied.

292 Thirteen patients with typical atrial flutter were studied.

293 The most common arrhythmia was atrial flutter, which occurred in 9% of this cohort.

294 n should be considered for all patients with atrial flutter who are older than 65 years of age.

295 gh-sensitivity CRP in 67 patients with AF or atrial flutter who underwent successful electrical CV.

296 Inpatients or observed patients with AF or atrial flutter will be enrolled.

297 Right atrial flutter with positive flutter waves in the inferi

298 compared the stroke rate in 59 patients with atrial flutter with rates in a sample in which age- and

299 Most right atrial flutters with positive flutter wave on surface EC

300 hs, 77% of patients were free from AF and/or atrial flutter without antiarrhythmic drug therapy.